Full-Time

IHC Laboratory Supervisor

Posted on 2/21/2026

Sonic Healthcare USA

Sonic Healthcare USA

51-200 employees

Laboratory and pathology testing services

No salary listed

Dallas, TX, USA

In Person

On-site in Dallas, TX; 2nd shift.

Category
Medical, Clinical & Veterinary (1)
Requirements
  • Bachelor's, or higher, degree in one of the chemical, physical, or biological sciences from an accredited institution has had at least four years of pertinent experience in an acceptable laboratory subsequent to qualifying.
  • Board of Certification (BOC) by the American Society of Clinical Pathologists (ASCP).
  • Minimum of 5 years’ experience as a Histology Technician or Histotechnologist including 3 years performing IHC procedures and/or 2 years’ experience as an Histology/IHC Supervisor.
  • State licensure, if required by state
Responsibilities
  • Supervises the daily operations of the Immunohistochemistry Department and personnel to ensure adherence to quality standards, deadlines, and established procedures.
  • Assists the Manager in developing, implementing, revising, interpreting, and enforcing the Standard Operating Procedures (SOP’s), company policies and procedures, and service standards.
  • Advises Manager of problems and concerns in the department and laboratory.
  • Complies data and prepares reports and may work on special assigned projects.
  • Performs all necessary functions required of a Immunohistochemistry Technician including:
  • Ensures compliance with all regulatory agencies.
  • Coordinates the proper storage of hazardous materials and the laboratory safety program.
  • Examines slides and/or blocks to ensure tissue preparation is meeting laboratory requirements.
  • Performs and documents daily quality control and quality assurance measures,
  • Prepares sections of human tissue for immunohistochemistry, in situ hybridization and immunofluoresence testing.
  • Performs both manual and automated testing for IHC, ISH and DIF samples as requested by a Pathologist.
  • Maintains strictest confidentiality.
  • Complies with all State, Federal, professional regulations as well as company and departmental rules, polices, and procedural manuals.
  • Adherence to CAP, CLIA, State Regulations, HIPAA, Safety and OSHA Regulations.
  • Performs other duties as assigned.
Desired Qualifications
  • Certification as a Histology Technician (HT) or Histology Technologist (HTL) by American Society of Clinical Pathology (ASCP) preferred

Sonic Healthcare USA provides laboratory testing and professional pathology services across the United States as part of Sonic Healthcare Limited, one of the world’s largest medical diagnostics groups. It operates through nine divisions and around eight thousand employees, following a federated model that puts medical leadership at the local level to ensure high-quality, community-based testing for doctors and patients. Its tests cover core diagnostic laboratory services and pathology expertise used by medical practitioners, hospitals, and community health services. The company aims to deliver precise, timely results and strong clinical partnerships to improve patient care by offering comprehensive laboratory testing and pathology support while maintaining close ties to local healthcare providers.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Austin, Texas

Founded

2014

Simplify Jobs

Simplify's Take

What believers are saying

  • Aging U.S. population drives cancer screening volumes through 2030.
  • National scaling via Sonic's sales and payer networks boosts Cairo reach.
  • Microba 19.99% stake opens gut health diagnostics expansion in 2025.

What critics are saying

  • Quest Diagnostics captures Cairo clients with faster oncology innovations within 12 months.
  • Labcorp diverts referrals using superior payer contracts in 15 months.
  • Medicare bundling slashes oncology reimbursements 20-30% post-Cairo integration.

What makes Sonic Healthcare USA unique

  • Cairo Diagnostics integrates hematology-oncology testing for comprehensive reports.
  • First major U.S. acquisition since 2021 targets high-margin oncology segment.
  • Bundled diagnostics from Cairo command premiums in competitive pathology market.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Company News

Newswise
Aug 22nd, 2025
Sonic Healthcare USA, Inc. Announces Acquisition of Cairo Diagnostics LLC to Expand Sonic's National Hematology Oncology Testing Capabilities

Sonic Healthcare USA, Inc. announces acquisition of Cairo Diagnostics LLC to expand Sonic's national hematology oncology testing capabilities.

PR Newswire
Aug 22nd, 2025
Sonic Healthcare Acquires Cairo Diagnostics

Sonic Healthcare USA, Inc. has acquired Cairo Diagnostics LLC to enhance its national hematology oncology testing capabilities. Founded by Dr. Sherif Ibrahim, Cairo is known for its integrated oncology testing approach, combining various diagnostic methods to provide comprehensive reports. This acquisition aims to expand Sonic's reach and improve service to oncologists nationwide, offering faster and more complete diagnostic solutions.

The West Australian
Mar 20th, 2024
Sonic Healthcare beefs up Swiss presence with $202m purchase of laboratory group Dr Risch

Sonic Healthcare will beef up its presence in Switzerland with the purchase of laboratory group Dr Risch for 117 million Swiss francs ($202m).

Business News Australia
Apr 27th, 2023
Sonic announces $611m in German acquisitions in April

Australias largest pathology company has today announced its second German acquisition this month, with binding agreements signed to purchase Medical Laboratori

Australian Financial Review
Nov 28th, 2022
Sonic Healthcare acquires major stake in Luke Reid’s Microba Life Sciences gut health testing business

Microba, an ASX-listed small-cap biotech, announced on Tuesday morning that Sonic would invest $17.8 million to acquire a 19.99 per cent stake in the company at 26¢ per share.

INACTIVE